Sign Out
Pregnancy: Fusidic acid: No effects during pregnancy are anticipated, since systemic exposure to fusidic acid is negligible.
Betamethasone valerate: There are no or limited amount of data from the use of topical betamethasone valerate in pregnant women. Studies in animals have shown reproductive toxicity. Fusidic acid + betamethasone valerate (Fucicort) should not be used during pregnancy unless the clinical condition of the woman requires treatment with fusidic acid and betamethasone valerate.
Breastfeeding: No effects on the breastfed newborn/infant are anticipated since the systemic exposure of topically applied fusidic acid and betamethasone valerate to a limited area of skin of the breastfeeding woman is negligible.
Fusidic acid + betamethasone valerate (Fucicort) can be used during breastfeeding but it is recommended to avoid applying fusidic acid + betamethasone valerate (Fucicort) on the breast.
Fertility: There are no clinical studies with fusidic acid + betamethasone valerate (Fucicort) regarding fertility.
Continue with Google